SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024498
Filing Date
2021-05-06
Accepted
2021-05-06 07:01:58
Documents
80
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-10q_20210331.htm   iXBRL 10-Q 2071141
2 EX-10.1 syrs-ex101_97.htm EX-10.1 71812
3 EX-31.1 syrs-ex311_6.htm EX-31.1 17647
4 EX-31.2 syrs-ex312_7.htm EX-31.2 17637
5 EX-32.1 syrs-ex321_8.htm EX-32.1 5962
6 EX-32.2 syrs-ex322_9.htm EX-32.2 6069
  Complete submission text file 0001564590-21-024498.txt   9024193

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA syrs-20210331.xsd EX-101.SCH 68979
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20210331_cal.xml EX-101.CAL 59441
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20210331_def.xml EX-101.DEF 238670
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20210331_lab.xml EX-101.LAB 515794
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20210331_pre.xml EX-101.PRE 426330
12 EXTRACTED XBRL INSTANCE DOCUMENT syrs-10q_20210331_htm.xml XML 1734613
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 21895712
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences